Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial.
- Resource Type
- Article
- Source
- Cancers; Feb2023, Vol. 15 Issue 4, p1239, 12p
- Subject
CELL metabolism DENDRITIC cells HOMOGRAFTS CONFIDENCE intervals LIFE expectancy GLIOMAS QUALITY of life GENOMICS RESEARCH funding IMMUNOTHERAPY OVERALL survival DISEASE remission - Language
- ISSN
- 20726694